Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFospropofol: A New Sedative-Hypnotic Agent for Monitored Anesthesia Care
Annals of Pharmacotherapy, 10/21/09
Moore GD et al. – Fospropofol is a viable addition to the class of sedative–hypnotic agents due to the minimization of unwanted adverse effects of propofol and maintenance of a favorable pharmacokinetic profile facilitating sedation, anxiolysis, and rapid recovery. However, there are limited safety data to justify its use without the presence of dedicated anesthesia personnel.
Related Articles
Use of analgesic and sedative drugs in the NICU: integrating clinical trials and laboratory data
Pediatric Research, 11/09/09
Relevance Score: 45%
Is Higher ASA Class Associated With an Increased Incidence of Adverse Events During Procedural Sedation in a Pediatric Emergency Department
Pediatric Emergency Care, 10/29/09
Relevance Score: 45%
Use of remifentanil as a sedative agent in critically ill adult patients: a meta-analysis
Anaesthesia, 11/11/09
Relevance Score: 44%
Nurse Reports of Adverse Events During Sedation Procedures at a Pediatric Hospital
Journal of PeriAnesthesia Nursing, 11/03/09
Relevance Score: 44%
The effect of intrathecal fentanyl on Cerebral State Index-guided sedation during spinal anaesthesia
Anaesthesia, 11/10/09
Relevance Score: 43%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole
Neuropsychopharmacology, 12/08/09
Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
Journal of Psychopharmacology, 12/08/09
Sponsor
Article Search
Sponsor